tetano
Editor, Senior Moderator
Clin Infect Dis. 2010 May 1;50(9):1249-51.
Intravenous zanamivir for patients with pneumonitis due to pandemic (H1N1) 2009 influenza virus.
H?rter G, Zimmermann O, Maier L, Schubert A, Mertens T, Kern P, W?hrle J.
University Hospital Ulm, Dept of Clinical Infectious Diseases and Clinical immunology, Comprehensive Infectious Diseases Center Ulm and Clinic of Internal Medicine III, Albert-Einstein-Allee 23, 89081 Ulm, Germany. georg.haerter@uniklinikulm.de
Abstract
We report on 2 critically ill patients with pneumonitis and acute respiratory distress syndrome due to pandemic (H1N1) 2009 influenza A virus who were treated with intravenous zanamivir and had favorable clinical outcomes. Zanamivir given intravenously may be a therapeutic option in patients with critical illness and mechanical ventilation.
PMID: 20367227 [PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/20367227
Intravenous zanamivir for patients with pneumonitis due to pandemic (H1N1) 2009 influenza virus.
H?rter G, Zimmermann O, Maier L, Schubert A, Mertens T, Kern P, W?hrle J.
University Hospital Ulm, Dept of Clinical Infectious Diseases and Clinical immunology, Comprehensive Infectious Diseases Center Ulm and Clinic of Internal Medicine III, Albert-Einstein-Allee 23, 89081 Ulm, Germany. georg.haerter@uniklinikulm.de
Abstract
We report on 2 critically ill patients with pneumonitis and acute respiratory distress syndrome due to pandemic (H1N1) 2009 influenza A virus who were treated with intravenous zanamivir and had favorable clinical outcomes. Zanamivir given intravenously may be a therapeutic option in patients with critical illness and mechanical ventilation.
PMID: 20367227 [PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/20367227